Rodgers Brothers Inc. Buys 420 Shares of Teleflex Incorporated (NYSE:TFX)

Rodgers Brothers Inc. increased its position in Teleflex Incorporated (NYSE:TFX) by 12.7% in the fourth quarter, Holdings Channel.com reports. The fund owned 3,740 shares of the medical technology company’s stock after acquiring an additional 420 shares during the quarter. Rodgers Brothers Inc.’s holdings in Teleflex were worth $666,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of TFX. FMR LLC grew its position in Teleflex by 70.1% during the third quarter. FMR LLC now owns 269,490 shares of the medical technology company’s stock worth $66,650,000 after buying an additional 111,086 shares in the last quarter. Townsquare Capital LLC purchased a new position in shares of Teleflex during the third quarter worth about $200,000. Glenmede Trust Co. NA increased its position in shares of Teleflex by 5.9% in the third quarter. Glenmede Trust Co. NA now owns 4,481 shares of the medical technology company’s stock worth $1,108,000 after purchasing an additional 249 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Teleflex by 2.3% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 333,260 shares of the medical technology company’s stock valued at $82,422,000 after purchasing an additional 7,379 shares in the last quarter. Finally, Public Sector Pension Investment Board lifted its position in Teleflex by 16.7% during the third quarter. Public Sector Pension Investment Board now owns 2,099 shares of the medical technology company’s stock valued at $519,000 after purchasing an additional 300 shares during the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Stock Up 0.3 %

Shares of Teleflex stock opened at $138.22 on Tuesday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex Incorporated has a 52-week low of $128.55 and a 52-week high of $249.91. The company’s 50 day moving average price is $158.33 and its 200-day moving average price is $189.25. The stock has a market capitalization of $6.41 billion, a price-to-earnings ratio of 27.48, a P/E/G ratio of 1.73 and a beta of 1.21.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03. The firm had revenue of $795.40 million for the quarter, compared to analysts’ expectations of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Equities research analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were given a $0.34 dividend. The ex-dividend date was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.98%. Teleflex’s dividend payout ratio is currently 95.77%.

Wall Street Analyst Weigh In

TFX has been the topic of a number of research analyst reports. Truist Financial decreased their price target on shares of Teleflex from $200.00 to $149.00 and set a “hold” rating on the stock in a report on Monday, March 3rd. Morgan Stanley lowered their price target on Teleflex from $275.00 to $191.00 and set an “overweight” rating on the stock in a research report on Wednesday, March 5th. Citizens Jmp cut Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday, February 27th. Royal Bank of Canada cut Teleflex from an “outperform” rating to a “sector perform” rating and decreased their price objective for the company from $220.00 to $155.00 in a report on Friday, February 28th. Finally, Piper Sandler reiterated a “neutral” rating and set a $140.00 price target (down from $255.00) on shares of Teleflex in a research report on Friday, February 28th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $182.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.